| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |